Thesis: How the plant cell synthesizes the pharmaceutical compounds?
VTT’s Research Scientist Suvi Häkkinen (MSc, Tech) has studied in her thesis alkaloid biosynthesis and metabolism in two Solanaceae plants, tobacco and Egyptian henbane.
The studies bring new information about the functions of genes involved with the biosynthesis of plant secondary metabolites. The results can be used in developing production of valuable pharmaceuticals in plant cell cultures.
Plants produce small-molecular-weight compounds, which are used for example to attract pollinators and in various defence-related reactions. These secondary metabolites are often produced in low quantities in plants. Moreover, they are often structurally very complex molecules, and therefore their chemical synthesis is challenging.
Alkaloids, such as morphine and paclitaxel, are secondary compounds which are used as pharmaceuticals. Using cell cultures these often valuable plant-based compounds can be produced in controlled conditions. The thesis of Suvi Häkkinen shows that increased knowledge of regulation of biosynthesis is needed to be able to engineer the production of these compounds in cell cultures.
In this work, a functional genomics-based technology for the discovery of genes involved in plant secondary metabolism was developed. As a result, two novel genes were discovered, which were suggested to be involved in tobacco alkaloid biosynthesis. In addition, a novel alkaloid in tobacco cell cultures was isolated and it was shown to exist in two isomeric forms.
When a gene involved in the alkaloid metabolism in Egyptian henbane was overexpressed in tobacco hairy roots, it was shown that added hyoscyamine was efficiently converted into pharmaceutically more valuable scopolamine. In addition, a majority of the produced scopolamine was secreted out of the cells, which facilitates the product recovery. The transportation of secondary metabolites was also studied by overexpressing a yeast transporter gene in tobacco cell cultures, and it was suggested that PDR5-type transporters can be used to stimulate the secretion of secondary metabolites in plant cells.
Suvi Häkkinen will defend her thesis ”A functional genomics approach to the study of alkaloid biosynthesis and metabolism in Nicotiana tabacum and Hyoscyamus muticus cell cultures” at the Helsinki University of Technology (address: Kemistintie 1, Espoo, Finland) on 7 November 2008.
tel. +358 20 722 4456
Further information on VTT:
Senior Vice President
Tel. +358 20 722 6747
VTT Technical Research Centre of Finland is the biggest contract research organization in Northern Europe. VTT provides high-end technology solutions and innovation services. From its wide knowledge base, VTT can combine different technologies, create new innovations and a substantial range of world-class technologies and applied research services, thus improving its clients' competitiveness and competence. Through its international scientific and technology network, VTT can produce information, upgrade technology knowledge and create business intelligence and value added to its stakeholders.
Suvi Häkkinen | VTT
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Mapping the interaction of a single atom with a single photon may inform design of quantum devices
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...